中国临床药理学杂志2024,Vol.40Issue(21) :3153-3157.DOI:10.13699/j.cnki.1001-6821.2024.21.017

盐酸达泊西汀片在中国健康受试者的生物等效性研究

Bioequivalence study of dapoxetine hydrochloride tablets in Chinese healthy subjects

肖功胜 孙宇宏 单娜 党艳妮 惠大永 苗琳琳 刘瑞霞 娄安锋 郭嘉华 刘峰
中国临床药理学杂志2024,Vol.40Issue(21) :3153-3157.DOI:10.13699/j.cnki.1001-6821.2024.21.017

盐酸达泊西汀片在中国健康受试者的生物等效性研究

Bioequivalence study of dapoxetine hydrochloride tablets in Chinese healthy subjects

肖功胜 1孙宇宏 2单娜 2党艳妮 2惠大永 2苗琳琳 2刘瑞霞 3娄安锋 3郭嘉华 4刘峰1
扫码查看

作者信息

  • 1. 陕西国际商贸学院医药学院,陕西咸阳 712046;陕西步长制药有限公司,陕西咸阳 712021
  • 2. 陕西步长制药有限公司,陕西咸阳 712021
  • 3. 河南(郑州)中汇心血管病医院Ⅰ期临床试验研究室,河南郑州 450000
  • 4. 天津汉一医药科技有限公司,天津 300409
  • 折叠

摘要

目的 评价盐酸达泊西汀片仿制药与原研药在中国健康受试者中单剂量空腹和餐后条件下给药的生物等效性.方法 用单中心、随机、开放、单次给药、两制剂、两周期、双交叉试验设计.空腹和餐后试验各入组36例受试者.在空腹或餐后条件下,单次口服盐酸达泊西汀片受试制剂和参比制剂60 mg,用液相色谱串联质谱法测定血浆中达泊西汀的浓度.用Phoenix WinNonlin 8.0软件计算主要药代动力学(PK)参数.结果 空腹组的盐酸达泊西汀片受试制剂和参比制剂主要PK参数:达泊西汀Cmax分别为(449.36±203.01)和(432.85±199.75)ng·mL-1,AUC0-t分别为(2 400.96±1 392.58)和(2 251.82±1 225.84)ng·mL-1·h,AUC0-∞分别为(2 529.94±1 498.05)和(2 371.06±1 305.22)ng·mL-1·h.餐后组的盐酸达泊西汀片受试制剂和参比制剂主要PK参数:达泊西汀Cmax分别为(651.29±179.38)和(672.83±249.42)ng·mL-1,AUC0-t分别为(3 391.27±1 358.73)和(3 314.53±1 360.39)ng·mL-1·h,AUC0-∞分别为(3 630.79±1 605.89)和(3 549.22±1 526.61)ng·mL-1·h.在空腹和餐后条件下,受试制剂与参比制剂主要PK参数的90%置信区间均在80.00%~125.00%,表明盐酸达泊西汀片受试制剂和参比制剂在空腹状态和餐后给药时均具有生物等效性.结论 盐酸达泊西汀片仿制药与原研药在中国健康受试者体内具有生物等效性.

Abstract

Objective To study the bioequivalence of generic and original dapoxetine hydrochloride tablets in Chinese healthy subjects after single dose under fasting and fed conditions.Methods A single-center,random,open,single-dose,two-preparations,double-period,crossover study was adopted.Fasting and fed tests were performed on 36 subjects each.Single oral dose 60 mg of test and reference pre parations were taken under fasting and fed conditions,respectively.Plasma concentration of dapoxetine was determined by liquid chromatography tandem mass spectrometry.The main pharmacokinetic(PK)parameters were calculated by Phoenix WinNonlin 8.0 software.Results The main PK parameters of the test and reference preparations of dapoxetine tablets in the fasting group were as follows:Cmax were(449.36±203.01)and(432.85±199.75)ng·mL-1;AUC0-t were(2 400.96±1 392.58)and(2 251.82±1 225.84)ng·mL-1·h;AUC0-∞ were(2 529.94±1 498.05)and(2 371.06±1 305.22)ng·mL-1·h.The main PK parameters of the test and reference preparations of dapoxetine tablets in the fed group were as follows:Cmax were(651.29±179.38)and(672.83±249.42)ng·mL-1;AUC0-t were(3 391.27±1 358.73)and(3 314.56±1 360.39)ng·mL-1·h;AUC0-∞ were(3 630.79±1 605.89)and(3 549.22±1 526.61)ng·mL-1·h.Under the fasting and fed conditions,the 90%confidence intervals of the main PK parameters of the test and reference preparations of dapoxetine tablets are 80.00%-125.00%.Conclusion Under the fasting and fed conditions,a single oral dose of generic and original dapoxetine hydrochloride tablets in Chinese healthy adult volunteers showed bioequivalence.

关键词

盐酸达泊西汀片/生物利用度/生物等效性/健康受试者/液相色谱-串联质谱

Key words

dapoxetine hydrochloride tablet/bioavailability/bioequivalence/healthy subject/liquid chromatography-tandem mass spectrometry

引用本文复制引用

出版年

2024
中国临床药理学杂志
中国药学会

中国临床药理学杂志

CSTPCD北大核心
影响因子:1.91
ISSN:1001-6821
段落导航相关论文